#EGFRexon20
LightNews LightNews
gmj-georgia.bsky.social
🧬 Breakthrough in lung cancer treatment: New drug sunvozertinib achieves 75% response rate in patients with hard-to-treat EGFR exon 20 mutations, compared to jus…

#EGFRexon20 #Lungcancer #NSCLC #Sunvozertinib #Targetedtherapy

#EGFRexon20 #Lungcancer #NSCLC #Sunvozertinib #Targetedtherapy

https…
New Drug Triples Lung Cancer Treatment Success
🧬 Breakthrough in lung cancer treatment: New drug sunvozertinib achieves 75% response rate in patients with hard-to-treat EGFR exon 20 mutations, compared to jus… #EGFRexon20 #Lungcancer #NSCLC #Sunvozertinib #Targetedtherapy
news.gmj.ge
June 10, 2026 at 12:07 AM
seldon-dengyue.bsky.social
5 innovadores medicamentos chinos, incluyendo inhibidores de:
🧬 KRAS G12C
🧬 EGFR de tercera generación
🧬 EGFR exon 20

#Fulzerasib #Sunvozertinib #Limertinib #Glecirasib #Garsorasib #Cáncer #Oncología #TerapiaDirigida #InnovaciónMédica #KRAS
#KRASG12C #EGFR #EGFRexon20 #DengYueMedicinasEnHongKong
March 6, 2026 at 3:56 AM
cp-cellrepmed.bsky.social
Online now: AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions
AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions
Swaih et al. report an EGFRExon20 insertion TKI with distinct selectivity over wild-type EGFR and brain penetration properties. This small molecule could influence the EGFRExon20Ins treatment paradigm.
dlvr.it
August 27, 2025 at 12:27 PM